| Somavert 30 mg powder and solvent for solution for injection EU/1/02/240/011-012 |
Pegvisomant |
Pfizer Europe MA EEIG |
— |
| Sutent 12.5 mg hard capsules EU/1/06/347/001 |
Sunitinib malate |
Pfizer Europe MA EEIG |
— |
| Sutent 25 mg hard capsules EU/1/06/347/002 |
Sunitinib malate |
Pfizer Europe MA EEIG |
— |
| Sutent 37.5 mg hard capsules EU/1/06/347/7-8 |
Sunitinib malate |
Pfizer Europe MA EEIG |
— |
| Sutent 50 mg hard capsules EU/1/06/347/003 |
Sunitinib malate |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.1 mg Capsule, hard EU/1/19/1377/007 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.25 mg Capsule, hard EU/1/19/1377/001-004 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.5 mg hard capsules EU/1/19/1377/009 |
Talazoparib tosilate |
Pfizer Europe MA EEIG |
— |
| Talzenna 1 mg Capsule, hard EU/1/19/1377/005-006 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion EU/1/10/633/001-2 |
Topotecan (as hydrochloride) |
Pfizer Europe MA EEIG |
— |
| Torisel 30 mg concentrate and solvent for solution for infusion EU/1/07/424/001 |
Temsirolimus |
Pfizer Europe MA EEIG |
— |
| TOVIAZ 4 mg prolonged-release tablets EU/1/07/386/1-5 |
Fesoterodine fumarate |
Pfizer Europe MA EEIG |
— |
| TOVIAZ 8 mg prolonged-release tablets EU/1/07/386/6-10 |
Fesoterodine fumarate |
Pfizer Europe MA EEIG |
— |
| Trazimera 150 mg powder for concentrate for solution for infusion EU/1/18/1295/001 |
Trastuzumab |
Pfizer Europe MA EEIG |
— |
| Trumenba suspension for injection in pre-filled syringe. Meningococcal group B vaccine (recombinant, adsorbed). EU/1/17/1187/001-006 |
Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family a), Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family b) |
Pfizer Europe MA EEIG |
— |
| TUKYSA 150 mg film-coated tablets EU/1/20/1526/002 |
Tucatinib |
Pfizer Europe MA EEIG |
— |
| TUKYSA 50 mg film-coated tablets EU/1/20/1526/001 |
Tucatinib |
Pfizer Europe MA EEIG |
— |
| Tygacil 50 mg powder for solution for infusion EU/1/06/336/01 |
Tigecycline |
Pfizer Europe MA EEIG |
— |
| Velsipity 2 mg film-coated tablets EU/1/23/1790/001-003 |
Etrasimod arginine |
Pfizer Europe MA EEIG |
— |
| VFEND 200 mg film-coated tablets EU/1/02/212/013-021 |
Voriconazole |
Pfizer Europe MA EEIG |
— |
| Vfend 200 mg powder for solution for infusion EU/1/02/212/025 |
Voriconazole |
Pfizer Europe MA EEIG |
— |
| Vfend 40 mg/ml powder for oral suspension EU/1/02/212/026 |
Voriconazole |
Pfizer Europe MA EEIG |
— |
| VFEND 50 mg film-coated tablets EU/1/02/212/001-009 |
Voriconazole |
Pfizer Europe MA EEIG |
— |
| Vizimpro 15 mg Film-coated tablet EU/1/19/1354/001 |
DACOMITINIB MONOHYDRATE |
Pfizer Europe MA EEIG |
— |
| Vizimpro 30 mg Film-coated tablet EU/1/19/1354/002 |
DACOMITINIB MONOHYDRATE |
Pfizer Europe MA EEIG |
— |
| Vizimpro 45 mg Film-coated tablet EU/1/19/1354/003 |
DACOMITINIB MONOHYDRATE |
Pfizer Europe MA EEIG |
— |
| Vydura 75 mg oral lyophilisate EU/1/22/1645/001-003 |
Rimegepant sulfate |
Pfizer Europe MA EEIG |
— |
| Vyndaqel 61 mg soft capsules EU/1/11/717/001 |
Tafamidis |
Pfizer Europe MA EEIG |
— |
| Vyndaqel 61 mg soft capsules EU/1/11/717/003-004 |
Tafamidis |
Pfizer Europe MA EEIG |
— |
| XALKORI 20 mg granules in capsules for opening EU/1/12/793/005 |
Crizotinib |
Pfizer Europe MA EEIG |
— |
| XALKORI 200 mg hard capsules EU/1/12/793/001-002 |
Crizotinib |
Pfizer Europe MA EEIG |
— |
| XALKORI 250 mg hard capsules EU/1/12/793/003-004 |
Crizotinib |
Pfizer Europe MA EEIG |
— |
| XELJANZ 1 mg/mL oral solution EU/1/17/1178/015 |
TOFACITINIB |
Pfizer Europe MA EEIG |
— |
| XELJANZ 10 mg film-coated tablets EU/1/17/1178/005-009 |
Tofacitinib citrate |
Pfizer Europe MA EEIG |
— |
| XELJANZ 11 mg film-coated tablets EU/1/17/1178/010-013 |
TOFACITINIB |
Pfizer Europe MA EEIG |
— |
| XELJANZ 5 mg film-coated tablets EU/1/17/1178/001-003 |
Tofacitinib citrate |
Pfizer Europe MA EEIG |
— |
| Zirabev 25 mg/ml concentrate for solution for infusion EU/1/18/1344/001-002 |
Bevacizumab |
Pfizer Europe MA EEIG |
— |
| Zoledronic Acid Hospira 4 mg/100 ml solution for infusion EU/1/12/800/003 |
Zoledronic acid monohydrate |
Pfizer Europe MA EEIG |
— |
| Zoledronic Acid Hospira 4 mg/5 ml concentrate for solution for infusion EU/1/12/800/001-002 |
Zoledronic acid monohydrate |
Pfizer Europe MA EEIG |
— |
| Zoledronic Acid Hospira 5 mg/100 ml solution for infusion EU/1/12/800/004 |
Zoledronic acid monohydrate |
Pfizer Europe MA EEIG |
— |